Home
News
Screeners
Insights
Omkar Pharmachem
7.
91
-0.41
(-4.93%)
Market Cap
₹7.99 Cr
PE Ratio
104.00
Industry
Chemicals
Buy
Sell
Company Performance:
1D
-4.93%
1M
+4.08%
6M
-73.19%
1Y
0.00%
5Y
0.00%
View Company Insights
Latest news about Omkar Pharmachem
Omkar Pharmachem shareholders approve all AGM resolutions unanimously
Oct 01, 2026
All three AGM resolutions passed with 100% votes in favour and zero against. Total valid votes polled stood at 19,39,772, representing 19.23% of outstanding shares. Promoter group cast no votes; public non-institutional holders drove all voting activity. Poll paper votes (19,39,050) significantly outnumbered remote e-votes (722).
Omkar Pharmachem profit falls 39% to ₹12.2 lakh in FY26
Sep 02, 2026
Omkar Pharmachem Q1FY27 net loss widens to ₹1 lakh on rising expenses
Aug 14, 2026
Omkar Pharmachem returns to profitability in FY26
Jun 01, 2026
Omkar Pharmachem board to meet on May 30 to consider FY26 results
May 21, 2026
More news about Omkar Pharmachem
14
May 26
Omkar Pharmachem Limited Announces Special Window for Transfer and Dematerialization of Physical Shares
Omkar Pharmachem Limited has notified BSE Limited of a special window for transfer and dematerialization of physical shares, open from February 05, 2026 to February 04, 2027, in accordance with SEBI Circular No. HO/38/13/11/2026-MIRSD-POD/1/3750/2026 dated January 30, 2026. The facility applies to physical transfer deeds executed prior to April 01, 2019, and requires original share certificates along with relevant supporting documents. Securities transferred under this window will be credited in demat mode and are subject to a one-year lock-in from the date of registration of transfer. Shareholders may contact the company's Registrar, M/s. Alankit Assignments Pvt. Ltd., for further queries.
27
Aug 25
Omkar Pharmachem Appoints New Independent Director, Sets Date for 30th AGM
Omkar Pharmachem Limited's board meeting on August 27, 2025, resulted in key decisions. The company's 30th AGM is scheduled for September 24, 2025, in Ahmedabad. Mr. Anupam Kumar Mishra, 55, was appointed as an Additional Non-executive Independent Director for a five-year term, subject to shareholder approval. The board also approved material related party transactions, appointed a scrutinizer for AGM voting, and approved the Director's report for FY 2024-25.
Omkar Pharmachem
7.
91
-
0.
41
(-
4.
93
%)
1 Year Returns:
0.00%
Industry Peers
Tata Chemicals
637.65
(+
0.
71
%)
Deepak Fertilisers & Petrochemicals
1,255.70
(-
6.
58
%)
Gujarat Narmada Valley Fert & Chem
546.25
(-
3.
18
%)
TANFAC Industries
3,500.00
(-
1.
25
%)
Gujarat Alkalies & Chemicals
574.35
(-
1.
84
%)
GHCL
391.40
(+
0.
17
%)
Grauer & Weil
77.66
(-
1.
48
%)
Chemplast Sanmar
207.91
(-
2.
09
%)
JG Chemicals
613.75
(-
3.
77
%)
Fischer Medical Ventures
28.27
(-
4.
69
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar